Related by context. Frequent words. (Click for all words.) 67 Patients Undergoing 67 Elderly Patients 66 Overactive Bladder 66 Heart Failure Patients 66 Hemodialysis 66 Early Diagnosis 66 Pulmonary Arterial Hypertension 65 Improves Survival 65 Urinary Incontinence 65 Breast Cancer Treatment 65 Pediatric Patients 65 Newly Diagnosed 64 Prostate Cancer Treatment 64 Chronic Heart Failure 64 Advanced Prostate Cancer 64 Regimens 64 Autoimmune Diseases 64 Anticoagulants 64 Patients Treated 64 Gastric Cancer 63 Autoimmune Disease 63 Lung Cancer Patients 63 Diabetic Patients 63 Medication Errors 63 Bladder Cancer 63 Psychiatric Disorders 63 Arrhythmias 63 Dialysis Patients 63 Surgical Treatment 63 Post Operative 63 Patient Outcomes 62 Low Dose 62 Stem Cell Transplant 62 Venous Thromboembolism 62 Clinical Outcomes 62 Cyclophosphamide 62 Acute Coronary Syndromes 62 Anticoagulation 61 Carotid 61 Cancer Treatments 61 Embolization 61 Renal Cell Carcinoma 61 Chronic Hepatitis B 61 Peripheral Arterial Disease 61 Urinary Tract Infections 61 Reduces Risk 61 Benign Prostatic Hyperplasia 61 Varicose Veins 61 Hepatitis C Virus 61 Hormone Therapy 61 Meta Analysis 61 Clinical Trial Results 61 Community Acquired Pneumonia 60 Cognitive Decline 60 Hepatocellular Carcinoma 60 Breast Reconstruction 60 Childhood Asthma 60 Cardiometabolic 60 Single Dose 60 Etanercept 60 Clinical Documentation 60 Neurostimulation 60 Gum Disease 60 Ischemic 60 Kidney Failure 60 Arch Neurol 60 Alcohol Consumption 60 Vascular Disease 60 Non Invasive 60 Anti TNF 60 Cataract Surgery 60 Apheresis 60 Cost Effectiveness 60 Preclinical Data 60 Vascular Access 60 J Nutr 60 Chronic Conditions 60 Peripheral Artery Disease 60 Metastatic Breast Cancer 60 Genetic Testing 60 Announces FDA Clearance 59 Cholesterol Levels 59 Treatment Options 59 Chronic Lymphocytic Leukemia 59 Gastric Bypass Surgery 59 Radiation Exposure 59 Patient Centered 59 Receives FDA Clearance 59 Prostate Cancer Patients 59 Allergic Rhinitis 59 Capecitabine 59 Receives Orphan Drug Designation 59 Lung Function 59 Dyslipidemia 59 Stereotactic 59 Sleep Disorder 59 Cardiovascular Events 59 Insulin Resistance 59 Percutaneous Coronary Intervention 59 receiving VELCADE 59 Randomized Controlled Trial